Nobel-winning optogenetics opens path to experimental therapies for blindness and Alzheimer’s

Optogenetics, a technique that uses light to control neurons, earned a 2026 Nobel Prize.

Researchers say the method is transforming brain mapping from a simple roadmap to a detailed, three-dimensional view.

The new precision is now being applied to develop experimental approaches aimed at restoring vision and tackling Alzheimer’s disease.

The work is being led by Karl Deisseroth and colleagues, who highlighted the need for tools that match the brain’s complexity.

While still in early stages, these efforts illustrate how a Nobel-winning discovery can quickly move toward therapeutic possibilities.